Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

被引:35
|
作者
Sorrig, Rasmus [1 ,2 ]
Klausen, Tobias W. [3 ]
Salomo, Morten [1 ]
Vangsted, Annette [1 ,2 ]
Gimsing, Peter [1 ]
机构
[1] Rigshosp, Dept Hematol, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Herlev Hosp, Hematol Res Lab, Herlev, Denmark
关键词
immunoparesis; infection; multiple myeloma; risk factors; STEM-CELL TRANSPLANTATION; T-REGULATORY CELLS; HIGH-DOSE THERAPY; IMMUNE STATUS; EARLY DEATH; MORBIDITY; MORTALITY;
D O I
10.1111/ejh.13190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Infections pose the greatest risk of early death in patients with Multiple Myeloma. However, few studies have analyzed the risk factors for infections in Multiple Myeloma patients. The aim of this study was to analyze the risk factors infections within a population-based MM cohort. Methods Using Danish registries (from 2005 to 2013), we analyzed all ICD-10 codes for infections within the first 6 months of Multiple Myeloma diagnosis in 2557 patients. Results Pneumonia and sepsis represented 46% of infections. Multivariable regression analysis showed that risk factors for pneumonia were male gender (HR 1.4; P = 0.001), ISS II (HR 1.6; P = 0.0004) and ISSIII (HR 1.8; P = 0.0004) and elevated LDH (HR 2.6; P = 0.0008). Risk factors for sepsis were high bone marrow plasma cell % (HR 1.1; P = 0.038), ISS II (HR 1.7; P = 0.007) ISS III (HR 2.0; P = 0.002) and creatinine (HR 2.1; P = 0.002). Neither immunoparesis (hypogammaglobulinemia) nor comorbidity was significant risk factors. Conclusions Our study suggests that tumor burden and renal impairment are risk factors for pneumonia and sepsis in the early phase of Multiple Myeloma.
引用
收藏
页码:182 / 190
页数:9
相关论文
共 50 条
  • [1] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [2] Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
    Rikke Faebo Larsen
    Mary Jarden
    Lisbeth Rosenbek Minet
    Ulf Christian Frølund
    Sören Möller
    Niels Abildgaard
    BMC Cancer, 20
  • [3] Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
    Larsen, Rikke Faebo
    Jarden, Mary
    Minet, Lisbeth Rosenbek
    Frolund, Ulf Christian
    Moeller, Soeren
    Abildgaard, Niels
    BMC CANCER, 2020, 20 (01)
  • [4] Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma
    Chun-Teng Huang
    Chia-Jen Liu
    Po-Shen Ko
    Han-Tsung Liu
    Yuan-Bin Yu
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Cheng-Hwai Tzeng
    Tzeon-Jye Chiou
    Jin-Hwang Liu
    Muh-Hwa Yang
    Ling-Ju Huang
    Chun-Yu Liu
    BMC Infectious Diseases, 17
  • [5] Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma
    Huang, Chun-Teng
    Liu, Chia-Jen
    Ko, Po-Shen
    Liu, Han-Tsung
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Yang, Muh-Hwa
    Huang, Ling-Ju
    Liu, Chun-Yu
    BMC INFECTIOUS DISEASES, 2017, 17
  • [6] Assessment of infection in newly diagnosed multiple myeloma patients: risk factors and main characteristics
    Chenyao Lin
    Hui Shen
    Shuimei Zhou
    Minghui Liu
    Anjie Xu
    Shuang Huang
    Changxin Shen
    Fuling Zhou
    BMC Infectious Diseases, 20
  • [7] Assessment of infection in newly diagnosed multiple myeloma patients: risk factors and main characteristics
    Lin, Chenyao
    Shen, Hui
    Zhou, Shuimei
    Liu, Minghui
    Xu, Anjie
    Huang, Shuang
    Shen, Changxin
    Zhou, Fuling
    BMC INFECTIOUS DISEASES, 2020, 20 (01) : 699
  • [8] Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay
    Riva, Eloisa
    Garrido, David
    Villano, Fiorella
    Bove, Virginia
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 434 - 442
  • [9] Prognosis of hepatitis B virus reactivation in newly diagnosed multiple myeloma in modern era therapy: a retrospective study
    Lv, Weiran
    Li, Xiaojin
    Xu, Jingbo
    Wang, Yun
    Huang, Hanying
    Hu, Fang
    Cui, Yingying
    Song, Yuanbin
    Chen, Lezong
    Wu, Bingyi
    Liang, Yang
    PEERJ, 2024, 12
  • [10] Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
    Chari, Ajai
    Mezzi, Khalid
    Zhu, Shao
    Werther, Winifred
    Felici, Diana
    Lyon, Alexander R.
    BMC CANCER, 2016, 16